TRADING HALTED

Roche Holding AG RHO-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 06/28/19 CET
247.60UNCH (UNCH)
52 week range
0.00 - 247.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close247.60
  • 52 Week High247.60
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap247,965.32M
  • Shares Out799.18M
  • 10 Day Average Volume-
  • Dividend9.54
  • Dividend Yield3.85%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close247.60
  • 52 Week High247.60
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap247,965.32M
  • Shares Out799.18M
  • 10 Day Average Volume-
  • Dividend9.54
  • Dividend Yield3.85%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)15.69
  • P/E (TTM)15.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/17/2022
  • Div Amount9.30
  • Split Date-
  • Split Factor-

Latest On Roche Holding AG

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz Ph.D.
Non-Executive Independent Chairman of the Board
Severin Schwan
Chief Executive Officer, Executive Director, Member of the Corporate Executive
Alan Hippe
Member of the Corporate Executive Committee, Chief Financial and Information Officer
Claudia Boeckstiegel
Member of the Enlarged Corporate Executive Committee, General Counsel
Address
Grenzacherstrasse 124
Basel
4058
Switzerland